App is deprecated.Last check on May 9, 2024.
BNT-103

BNT-103

App Report, Market and Ranking Data
category
price
Free
Reviews
0 (0)
United States United States
Description
BNT-103™ is a prescription digital therapeutic specifically designed to treat the symptoms of anxiety and depression related to cancer.

Delivered via a mobile app, BNT-103 is a digital version of Cognitive Behavioral Stress Management (CBSM), a behavioral treatment program that has been used and studied extensively in cancer patients for over 20 years. BNT-103 provides cognitive behavioral therapy, relaxation therapy, stress management techniques and coping strategies as an adjunct to other medical treatments for adult cancer patients. 

BNT-103’s Group forum provides a welcoming virtual setting for patients to connect with each other for encouragement, guidance, and understanding. Patients can respond to Check In prompts from the moderator openly in the Group Feed, or reach out to other group members in a Direct Message to discuss personal struggles or offer support. 
 
BNT-103 can only be accessed through a prescription.  Please consult with your doctor if you are interested in accessing BNT-103.
Category Ranking
Not enough information to display the data.
Review Breakdown
Not enough information to display the data.
Screenshots
Download & Revenue
DOWNLOAD N/AApr 2024Worldwide
REVENUEN/AApr 2024Worldwide
download revenue
About
Bundle Id
com.bluenotetx.bnt103
Min Os. Version
11.0
Release Date
Wed, Sep 8, 2021
Update Date
Mon, Mar 7, 2022
Content Rating
17+
Has IMessage
No
Support Watch
No
Support Siri
No
File Size
78.54MB
Has Game Center
No
Family Sharing
No
Support Passbook
No
Supported Languages
English
What's New
version
3.3.0
updated
2 years ago
App enhancements including improved user stability and minor bug fixes.
Newsletter

Subscribe our newsletter and get useful information every week.

Stay Ahead of the Market with StoreSpy
Never miss opportunities
Watch your competitors closely
Start boosting your app right away
Start Now
stay a head